Procurements: Medicinal products for the blood and blood-forming organs
10 archived procurements
Medicinal products for the blood and blood-forming organs have been procured by organizations such as St James's Hospital, and Irish Blood Transfusion Service.
Historically, suppliers within this area have been Novo Nordisk Healthcare AG, Octapharma AG, Shire Pharmaceuticals Ireland Ltd, Swedish Orphan Biovitrum Ltd (Sobi Ltd),, and TCP Homecare Ltd.
- Medical equipments, pharmaceuticals and personal care products (9 new procurements)
- Pharmaceutical products (1)
- Medicinal products for the blood, blood-forming organs and the cardiovascular system
- Medicinal products for the blood and blood-forming organs ⬅️
Recent procurements of medicinal products for the blood and blood-forming organs in Ireland
2023-06-13
Fibrinogen concentrate used for congenital afibrinogenaemia and dysfibrinogenaemia (Irish Blood Transfusion Service)
Human fibrinogen concentrate is used for congenital afibrinogenaemia and dysfibrinogenaemia states for treatment of bleeding complications. It is also used in acquired hypofibrinogenemia conditions such as massive haemorrhage, acquired coagulopathy, liver disease with bleeding and in obstetric haemorrhage. The product should be licensed for these clinical indications and approved by the HPRA. Fibrinogen, in presence of thrombin, activates FVIII and calcium, which is necessary to convert fibrinogen into … View the procurement »
Human fibrinogen concentrate is used for congenital afibrinogenaemia and dysfibrinogenaemia states for treatment of bleeding complications. It is also used in acquired hypofibrinogenemia conditions such as massive haemorrhage, acquired coagulopathy, liver disease with bleeding and in obstetric haemorrhage. The product should be licensed for these clinical indications and approved by the HPRA. Fibrinogen, in presence of thrombin, activates FVIII and calcium, which is necessary to convert fibrinogen into … View the procurement »
2018-05-16
Provision of Bypassing agents for the treatment of Haemophilia with inhibitors (St James's Hospital)
Provision of Bypassing agents for the treatment of Haemophilia with inhibitors for St James’s Hospital, the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA) 2018. View the procurement »
Provision of Bypassing agents for the treatment of Haemophilia with inhibitors for St James’s Hospital, the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA) 2018. View the procurement »
2018-03-16
Provision of Von Willebrand Factor (pdFVIII with VWF) (St James's Hospital)
Invitation to Tender for the Provision of Von Willebrand Factor (pdFVIII with VWF) for St James’s Hospital, the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA) 2018. View the procurement »
Invitation to Tender for the Provision of Von Willebrand Factor (pdFVIII with VWF) for St James’s Hospital, the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA) 2018. View the procurement »
2017-11-10
Recombinant Coagulation Factor VIII (St James's Hospital)
Recombinant Coagulation Factor VIII. View the procurement »
Recombinant Coagulation Factor VIII. View the procurement »
2017-09-15
Provision of Coagulation Recombinant Factor VIII 2017 (St James's Hospital)
Provision of Coagulation Recombinant Factor VIII 2017. View the procurement »
Provision of Coagulation Recombinant Factor VIII 2017. View the procurement »
2017-04-13
Provision of Cold Chain Services for the Haemophilia Home Patient Management Programme 2017 (St James's Hospital)
Provision of Cold Chain Services for the Haemophilia Home Patient Management Programme 2017. View the procurement »
Provision of Cold Chain Services for the Haemophilia Home Patient Management Programme 2017. View the procurement »
2017-03-16
Provision of Coagulation Factor X Concentrate to St James's Hospital (SJH), the Irish Blood Transfusion Board... (St James's Hospital)
Provision of Coagulation Factor X Concentrate to St James's Hospital (SJH), the Irish Blood Transfusion Board (IBTS), the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA). View the procurement »
Provision of Coagulation Factor X Concentrate to St James's Hospital (SJH), the Irish Blood Transfusion Board (IBTS), the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA). View the procurement »
2016-09-12
The Provision of Coagulation Recombinant Factor IX 2016 (St James's Hospital)
The Provision of Coagulation Recombinant Factor IX 2016. View the procurement »
The Provision of Coagulation Recombinant Factor IX 2016. View the procurement »
2015-09-09
The Provision of Recombinant Factor VIII (St James's Hospital)
Invitation to tender for the Provision of Recombinant Factor VIII to St James's Hospital (SJH), the Irish Blood Transfusion Board (IBTS), the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Agency (CA). View the procurement »
Invitation to tender for the Provision of Recombinant Factor VIII to St James's Hospital (SJH), the Irish Blood Transfusion Board (IBTS), the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Agency (CA). View the procurement »
2012-12-05
VonWillebrand Factor - Provision of vonWillebrand Factor (pdFVIII with vWF) (St James's Hospital)
Supply and delivery of vonWillebrand Factor (pdFVIII with vWF) 800,000 iu over 2 year period. View the procurement »
Supply and delivery of vonWillebrand Factor (pdFVIII with vWF) 800,000 iu over 2 year period. View the procurement »